Jerini News
Most Popular Jerini Story
Shire to buy Jerini in $521M deal
With an eye toward snapping up a late-stage orphan drug for hereditary angiodema - a rare genetic disease -- Shire has agreed to pay $521 million to acquire Berlin-based Jerini AG. That's a whopping... Read more...
Latest Headlines
- October 10, 2008
- July 3, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
